Percutaneous Transluminal Angioplasty Balloons - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510251594

Publication Date:

October 5, 2024

Pages:

119

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Percutaneous Transluminal Angioplasty (PTA) is a minimally invasive medical procedure used for the treatment of various cardiovascular diseases such as atherosclerosis, peripheral artery disease, and coronary artery disease. PTA balloons are employed to widen or dilate narrowed or blocked blood vessels, thus allowing for better blood flow.
The global market for Percutaneous Transluminal Angioplasty Balloons was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Percutaneous Transluminal Angioplasty Balloons, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Percutaneous Transluminal Angioplasty Balloons by region & country, by Type, and by Application.
The Percutaneous Transluminal Angioplasty Balloons market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Transluminal Angioplasty Balloons.
麻豆原创 Segmentation
By Company
Abbott
B. Braun Melsungen AG
Boston Scientific Corporation
Cook Medical
Cordis
Medtronic
MicroPort Scientific Corporation
Opto Circuits (India) Ltd.
Spectranetics (Philips Healthcare)
Terumo Corporation
Segment by Type:
Conventional Balloons
Drug Eluting Balloons
Cutting and Scoring Balloons
Segment by Application
Coronary Angioplasty
Peripheral Angioplasty
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Percutaneous Transluminal Angioplasty Balloons manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Percutaneous Transluminal Angioplasty Balloons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Percutaneous Transluminal Angioplasty Balloons in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Percutaneous Transluminal Angioplasty Balloons Product Introduction
1.2 Global Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Size Forecast
1.2.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Value (2019-2030)
1.2.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume (2019-2030)
1.2.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Price (2019-2030)
1.3 Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Trends & Drivers
1.3.1 Percutaneous Transluminal Angioplasty Balloons Industry Trends
1.3.2 Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Drivers & Opportunity
1.3.3 Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Challenges
1.3.4 Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Percutaneous Transluminal Angioplasty Balloons Players Revenue Ranking (2023)
2.2 Global Percutaneous Transluminal Angioplasty Balloons Revenue by Company (2019-2024)
2.3 Global Percutaneous Transluminal Angioplasty Balloons Players Sales Volume Ranking (2023)
2.4 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Company Players (2019-2024)
2.5 Global Percutaneous Transluminal Angioplasty Balloons Average Price by Company (2019-2024)
2.6 Key Manufacturers Percutaneous Transluminal Angioplasty Balloons Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Percutaneous Transluminal Angioplasty Balloons Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Percutaneous Transluminal Angioplasty Balloons
2.9 Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Competitive Analysis
2.9.1 Percutaneous Transluminal Angioplasty Balloons 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Percutaneous Transluminal Angioplasty Balloons Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Angioplasty Balloons as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Conventional Balloons
3.1.2 Drug Eluting Balloons
3.1.3 Cutting and Scoring Balloons
3.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Type
3.2.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Value, by Type (2019-2030)
3.2.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Value, by Type (%) (2019-2030)
3.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Type
3.3.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume, by Type (2019-2030)
3.3.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume, by Type (%) (2019-2030)
3.4 Global Percutaneous Transluminal Angioplasty Balloons Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Coronary Angioplasty
4.1.2 Peripheral Angioplasty
4.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Application
4.2.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Value, by Application (2019-2030)
4.2.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Value, by Application (%) (2019-2030)
4.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Application
4.3.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume, by Application (2019-2030)
4.3.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume, by Application (%) (2019-2030)
4.4 Global Percutaneous Transluminal Angioplasty Balloons Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Region
5.1.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Region (2019-2024)
5.1.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Region (2025-2030)
5.1.4 Global Percutaneous Transluminal Angioplasty Balloons Sales Value by Region (%), (2019-2030)
5.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Region
5.2.1 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Region (2019-2024)
5.2.3 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Region (2025-2030)
5.2.4 Global Percutaneous Transluminal Angioplasty Balloons Sales Volume by Region (%), (2019-2030)
5.3 Global Percutaneous Transluminal Angioplasty Balloons Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
5.4.2 North America Percutaneous Transluminal Angioplasty Balloons Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
5.5.2 Europe Percutaneous Transluminal Angioplasty Balloons Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
5.6.2 Asia Pacific Percutaneous Transluminal Angioplasty Balloons Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
5.7.2 South America Percutaneous Transluminal Angioplasty Balloons Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
5.8.2 Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Percutaneous Transluminal Angioplasty Balloons Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Percutaneous Transluminal Angioplasty Balloons Sales Value
6.2.1 Key Countries/Regions Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.2.2 Key Countries/Regions Percutaneous Transluminal Angioplasty Balloons Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.3.2 United States Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.4.2 Europe Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.5.2 China Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.5.3 China Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.6.2 Japan Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.7.2 South Korea Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.8.2 Southeast Asia Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Percutaneous Transluminal Angioplasty Balloons Sales Value, 2019-2030
6.9.2 India Percutaneous Transluminal Angioplasty Balloons Sales Value by Type (%), 2023 VS 2030
6.9.3 India Percutaneous Transluminal Angioplasty Balloons Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.1.5 Abbott Recent Development
7.2 B. Braun Melsungen AG
7.2.1 B. Braun Melsungen AG Company Information
7.2.2 B. Braun Melsungen AG Introduction and Business Overview
7.2.3 B. Braun Melsungen AG Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.2.4 B. Braun Melsungen AG Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.2.5 B. Braun Melsungen AG Recent Development
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Company Information
7.3.2 Boston Scientific Corporation Introduction and Business Overview
7.3.3 Boston Scientific Corporation Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Boston Scientific Corporation Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.3.5 Boston Scientific Corporation Recent Development
7.4 Cook Medical
7.4.1 Cook Medical Company Information
7.4.2 Cook Medical Introduction and Business Overview
7.4.3 Cook Medical Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cook Medical Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.4.5 Cook Medical Recent Development
7.5 Cordis
7.5.1 Cordis Company Information
7.5.2 Cordis Introduction and Business Overview
7.5.3 Cordis Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cordis Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.5.5 Cordis Recent Development
7.6 Medtronic
7.6.1 Medtronic Company Information
7.6.2 Medtronic Introduction and Business Overview
7.6.3 Medtronic Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Medtronic Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.6.5 Medtronic Recent Development
7.7 MicroPort Scientific Corporation
7.7.1 MicroPort Scientific Corporation Company Information
7.7.2 MicroPort Scientific Corporation Introduction and Business Overview
7.7.3 MicroPort Scientific Corporation Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.7.4 MicroPort Scientific Corporation Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.7.5 MicroPort Scientific Corporation Recent Development
7.8 Opto Circuits (India) Ltd.
7.8.1 Opto Circuits (India) Ltd. Company Information
7.8.2 Opto Circuits (India) Ltd. Introduction and Business Overview
7.8.3 Opto Circuits (India) Ltd. Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Opto Circuits (India) Ltd. Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.8.5 Opto Circuits (India) Ltd. Recent Development
7.9 Spectranetics (Philips Healthcare)
7.9.1 Spectranetics (Philips Healthcare) Company Information
7.9.2 Spectranetics (Philips Healthcare) Introduction and Business Overview
7.9.3 Spectranetics (Philips Healthcare) Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Spectranetics (Philips Healthcare) Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.9.5 Spectranetics (Philips Healthcare) Recent Development
7.10 Terumo Corporation
7.10.1 Terumo Corporation Company Information
7.10.2 Terumo Corporation Introduction and Business Overview
7.10.3 Terumo Corporation Percutaneous Transluminal Angioplasty Balloons Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Terumo Corporation Percutaneous Transluminal Angioplasty Balloons Product Offerings
7.10.5 Terumo Corporation Recent Development
8 Industry Chain Analysis
8.1 Percutaneous Transluminal Angioplasty Balloons Industrial Chain
8.2 Percutaneous Transluminal Angioplasty Balloons Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Percutaneous Transluminal Angioplasty Balloons Sales Model
8.5.2 Sales Channel
8.5.3 Percutaneous Transluminal Angioplasty Balloons Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott
B. Braun Melsungen AG
Boston Scientific Corporation
Cook Medical
Cordis
Medtronic
MicroPort Scientific Corporation
Opto Circuits (India) Ltd.
Spectranetics (Philips Healthcare)
Terumo Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.